MedTrace Logo

Clinical Study to Investigate the Sleep Quality Enhancing Effect of GABA

NCT04857021 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-09-20

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of dietary supplement GABA in subjects with mild, transient sleep disorder.

Conditions

  • Sleep Disturbance

Interventions

DIETARY_SUPPLEMENT

GABA

oral administration of GABA capsule once daily before sleep

DIETARY_SUPPLEMENT

Placebo

oral administration of placebo capsule once daily before sleep

Sponsors & Collaborators

  • Amorepacific Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-14
Primary Completion
2021-02-15
Completion
2021-06-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04857021 on ClinicalTrials.gov